Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Baricitinib”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Testing effectiveness (Phase 2)Study completedNCT05016297
What this trial is testing

Efficacy and Safety of Baricitinib in Sjogren's Syndrome

Who this might be right for
Sjogren's Syndrome
Peking Union Medical College Hospital 87
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06797310
What this trial is testing

Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

Who this might be right for
Alopecia Areata
National Taiwan University Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07449910
What this trial is testing

Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial

Who this might be right for
Acute Ichemic StrokeAnterior Cerebral Artery StrokeBaricitinib
The First Affiliated Hospital of University of Science and Technology of China 750
Large-scale testing (Phase 3)Study completedNCT04421027
What this trial is testing

Baricitinib (LY3009104) in Participants With COVID-19

Who this might be right for
COVID-19
Eli Lilly and Company 1,525
Large-scale testing (Phase 3)Study completedNCT01721057
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 684
Testing effectiveness (Phase 2)UnknownNCT06114407
What this trial is testing

Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib

Who this might be right for
Spondyloarthritis, Axial
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 184
Testing effectiveness (Phase 2)Study completedNCT04774224
What this trial is testing

Baricitinib in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
St Vincent's Institute of Medical Research 91
Large-scale testing (Phase 3)Ended earlyNCT03616912
What this trial is testing

Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Eli Lilly and Company 830
Large-scale testing (Phase 3)Study completedNCT03334396
What this trial is testing

Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 660
Large-scale testing (Phase 3)WithdrawnNCT04970719
What this trial is testing

Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus

Who this might be right for
COVID-19 Pneumonia
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
Large-scale testing (Phase 3)Study completedNCT01885078
What this trial is testing

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 2,877
Testing effectiveness (Phase 2)UnknownNCT04393051
What this trial is testing

Baricitinib Compared to Standard Therapy in Patients With COVID-19

Who this might be right for
Covid-19SARS-CoV 2SARS Pneumonia
Azienda Ospedaliero, Universitaria Pisana 126
Large-scale testing (Phase 3)Looking for participantsNCT04972760
What this trial is testing

Baricitinib in Patients With Relapsing or naïve Dermatomyositis

Who this might be right for
Dermatomyositis
Assistance Publique - Hôpitaux de Paris 62
Large-scale testing (Phase 3)Looking for participantsNCT02735707
What this trial is testing

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Who this might be right for
Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht 20,000
Early research (Phase 1)Study completedNCT02340104
What this trial is testing

Measure Baricitinib (LY3009104) Absorption in Healthy Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 8
Large-scale testing (Phase 3)WithdrawnNCT05858515
What this trial is testing

REVERSE-Long COVID-19 With Baricitinib Study

Who this might be right for
Post-Acute COVID-19 Syndrome
Vanderbilt University Medical Center
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Testing effectiveness (Phase 2)Study completedNCT03026504
What this trial is testing

Baricitinib in Relapsing Giant Cell Arteritis

Who this might be right for
Arteritis, Giant Cell
Matthew J Koster 15
Testing effectiveness (Phase 2)Ended earlyNCT03742973
What this trial is testing

Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA

Who this might be right for
Primary Biliary Cholangitis
Eli Lilly and Company 2
Post-approval studies (Phase 4)Study completedNCT03915964
What this trial is testing

Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 2,659
Next Page